AI app aims to help frontline workers diagnose neglected skin diseases
NCT ID NCT07506967
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a mobile app using artificial intelligence can help frontline health workers in sub-Saharan Africa better diagnose skin-related neglected tropical diseases, like leprosy and scabies. Researchers will collect images from dermatologists to train the AI, then have health workers use the app to see if their diagnostic accuracy improves. The goal is to boost early detection and care in underserved communities.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AI-powered mobile app for diagnosing skin diseases
What this could lead to
If successful, this AI tool could help frontline health workers in remote areas detect skin diseases earlier, improving treatment and disease tracking.
What could go wrong
This is an early-stage study testing the app's feasibility. The AI may not improve diagnosis enough, and results may not apply to all regions or diseases.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS LEISHMANIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Armauer Hansen Research Institute (AHRI)
Addis Ababa, Addis Ababa, Ethiopia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Centre Hospitalier de l'Ordre de Malte (CHOM)
Dakar, Dakar, Senegal
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Kenya Medical Research Institute (KEMRI)
Kisumu, Nyanza, Kenya
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Leprosy and Tuberculosis Relief Initiative Nigeria (LTR)
Jos, Plateau State, Nigeria
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Université Catholique de Bukavu (UCB)
Bukavu, South Kivu, Democratic Republic of the Congo
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••